ISRCTN54261005
Completed
Not Applicable
Treatment of uncomplicated falciparum malaria in Bobo-Dioulasso, Burkina Faso: comparison of amodiaquine sulfadoxine-pyrimethamine with Coartem
Institute of Research in Health Sciences (Institut de Recherches en Sciences de la Sante [IRSS]) (Burkina Faso)0 sites521 target enrollmentStarted: May 5, 2006Last updated:
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Institute of Research in Health Sciences (Institut de Recherches en Sciences de la Sante [IRSS]) (Burkina Faso)
- Enrollment
- 521
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1\. Age \=6 months
- •2\. Fever (\=37\.5 or history of fever in the last 24 hours)
- •3\. Provision of informed consent
- •4\. P. falciparum mono infection
- •5\. Parasite density \>2000 microliters and \=200,000 microliters
Exclusion Criteria
- •1\. Evidence of severe malaria
- •2\. History of side effects to the investigational product
- •3\. Pregnancy
- •4\. Repeated vomiting of study medication on day 0
- •5\. Hemoglobin \<5 g/Dl
- •6\. Evidence of concomitant febrile illness
Investigators
Similar Trials
Completed
Not Applicable
Treatment of uncomplicated falciparum malaria in Bobo-Dioulasso, Burkina Faso: comparison of artemether/lumefantrine, dihydroartemisinin/piperaquine, and amodiaquine/sulfadoxine-pyrimethamineISRCTN94367569Institut de Recherche en Science de la Sante (IRSS) (Burkina Faso)528
Completed
Not Applicable
Treatment of uncomplicated childhood malaria by artemether-lumefantrine (Coartem®) efficacy, effectiveness, safety and genotyping in TanzaniaMalaria in under five childrenInfections and InfestationsMalariaISRCTN69189899ICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR)360
Recruiting
Phase 4
Therapeutic efficacy surveillance of malaria treatment and drug resistance monitoring in Gia Lai and Phu Yen provinces of Central VietnamACTRN12621001085864Australian Defence Force Malaria and Infectious Disease Institute210
Completed
Not Applicable
Controlled Human Malaria Infection after bites from mosquitoes infected with NF135.C10 or NF166.C8 Plasmodium falciparum parasitesNL-OMON40942niversitair Medisch Centrum Sint Radboud24
Active, not recruiting
Phase 1
Controlled human malaria infection after immunization with frozen Plasmodium falciparum parasites under chloroquine prophylaxisEUCTR2012-000322-21-NLSanaria Inc.